In the search for novel bioactive products from filamentous fungi, sterols and triterpenoids found in Phycomyces blakesleeanus were analyzed using semipreparative HPLC, GC-MS, and NMR techniques. Structures proposed for the three new compounds identified, phycomysterol A (1), phycomysterol B (2), and neoergosterol (3), were confirmed by chemical synthesis. Phycomysterols possess a new natural 19-norergostane skeleton with an aromatic B ring. Phycomysterol A showed anti-HIV activity.
In the search for novel bioactive products from filamentous fungi, sterols and triterpenoids found in Phycomyces blakesleeanus were analyzed using semipreparative HPLC, GC-MS, and NMR techniques. Structures proposed for the three new compounds identified, phycomysterol A (1), phycomysterol B (2), and neoergosterol (3), were confirmed by chemical synthesis. Phycomysterols possess a new natural 19-norergostane skeleton with an aromatic B ring. Phycomysterol A showed anti-HIV activity.
Fungi have been one of the main natural sources of biologically active substances since the discovery of antibiotics. Searching for new bioactive products from filamentous fungi, chemical analysis and biological screening of metabolites from Gibberella fujikuroi have been the subject of our work over the past few years. [1] [2] [3] We recently began studying Phycomyces blakesleeanus (Mucoraceae), which is a fungal producer of -carotene (provitamin A), riboflavine (vitamin B 2 ), pyridoxine (vitamin B 6 ), ergosterol (provitamin D 2 ), biotin, and nicotinic acid. 4, 5 Therefore, oil from Phycomyces could be an interesting alimentary vitamin complement, if it were proven to be free of mycotoxins. We have identified more than forty nontoxic compounds among the acidic metabolites from P. blakesleeanus 6 and are now working on neutral metabolites. In the mycelium of P. blakesleeanus (NRRL1555 wild strain) we have found eleven sterols previously unreported in Phycomyces. These include the new natural sterols (1-3; Chart 1) with a 19-norergostane skeleton and an aromatic B ring. Previous studies of sterols from Phycomyces at the University College of Wales yielded a number of new sterols (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) and certain aspects of fungal ergosterol biosynthesis were resolved. [7] [8] [9] [10] [11] However, some sterols present in the fungus were not identified. 9 
Results and Discussion
Sterol and triterpene mixtures isolated from P. blakesleeanus were subjected to semipreparative HPLC. Fractions obtained were studied by NMR spectroscopy and aliquots were treated with N,O-bis(trimethylsilyl)trifluoroacetamide (BSTFA) to form TMS derivatives for analysis by GC-MS. The sterol ester mixture was saponified, and the nonsaponifiable fraction was analyzed as described above. Results are shown in Table 1 . Proportions are only approximate because they were determined from the area of the gas chromatogram peaks, based on total ion current response data. TMS-ethers of sterols were used for GC-MS analysis, instead of free sterols, because the former have better chromatographic properties and afford highly characteristic modes of fragmentation from which structural details may be inferred. 12 In the mass spectrum of 1, as the TMS-ether, the molecular ion was consistent with the TMS derivative of a sterol with the molecular formula C 27 the side chain double bond at ∆ 22 , allowing the characterization of structure 3. Mass spectra of TMS-ethers of compounds 4, 5, 7, 8, 10, and 12-15 matched those previously described. 12, 13 Interpretation of the MS from the TMS-ethers of compounds 6, 9, 11, and 16-20 was carried out on the basis of their fragmentation patterns 12, 14 and was facilitated by the previously reported MS of the corresponding free sterols and their acetyl derivatives. [8] [9] [10] [15] [16] [17] [18] Semipreparative HPLC yielded compounds 4-8, 11, 12, and 16. 1 H NMR spectra of 4-8 and 12, as well as 13 C NMR of 6, agreed with those previously reported. [19] [20] [21] [22] In the 1 21, 23 confirmed their structures. The TMSsterol at T RR′ ) 1.325 showed an MS which matched both mass spectra of TMS derivatives from sitosterol (21) 12 and clionasterol (24-epi-sitosterol). 14 The corresponding fungal sterol could not be isolated for NMR analysis, but a sample of true sitosterol was obtained from the plant Santolina viscosa and its 24R stereochemistry was confirmed by 1 H NMR. 24 Plant sitosterol was treated with BSTFA and analyzed by GC-MS, showing the same T RR′ as the fungal sterol 21. The TMS-ether of clionasterol, also contained in the sterol mixture from S. viscosa, had a T RR′ ) 1.292 under the same GC-MS conditions. Synthetic compounds 2 and 3 had previously been obtained for the preparation of oestrone, 25 but no previous reports about structure 1 have been found. To confirm the structure proposed for phycomysterol A (1) and to study its biological activity, chemical synthesis of 1, starting from commercially available ergosterol (12) , was carried out (Scheme 1). The acetate 22 was prepared following the modified photochemical procedure of Mosettig and Scheer. 26, 27 Aldehyde 23 was obtained from 22, without isomerization at C-20, by ozonolysis in the presence of pyridine. The condensation of 23 with the kinetic enolate of 3-methyl-2-butanone yielded a mixture (1:2.7) of the 22R and 22S stereoisomers of the aldol 24. Dehydration of the epimeric mixture led to the conjugated enone 25 and selective reduction of its conjugated double bond furnished the ketone 26. Finally, the Wittig olefination of 26 afforded 1. Moreover, saponification of 22 generated 3, and selective hydrogenation of 3 led to 2. Synthetic 1, 2 and 3 were treated with BSTFA and were analyzed by GC-MS. Mass spectra and relative retention times of the synthetic TMSethers were identical to those of the TMS derivatives of the corresponding fungal sterols.
Recently, substantial levels of 19-norcholesta-5,7,9-trien-3 -ol have been found, by means of GC-MS techniques, in blood and feces from patients with the Smith-LemliOpitz syndrome. 28 However, it has been reported that a part of the 19-norcholesta-5,7,9-trien-3 -ol measured derives from cholesta-5,8-dien-3 -ol by an aromatization process which takes place during the GC-MS analysis. The artifact proportion varied directly with the amount of material injected in the GC-MS apparatus, and inversely with the injector head pressure. 29 Equally, neoergosterol (3) found in P. blakesleeanus might be an artifact from lichesterol (15) . Thereby, an authentic sample of liches- 31 13 C NMR spectra of 10 and 30, confirmed their structures. Derivatization of synthetic 10 and subsequent analysis by GC-MS, confirmed the structure proposed for the corresponding fungal sterol. Synthetic 15 was treated with BSTFA and analyzed by GC-MS, under the same conditions used for the fungal sterol analysis. In the chromatogram, a major and a minor peak appeared. The major peak showed MS and T RR′ identical to those for fungal lichesterol, confirming the proposed structure 15. The minor peak had T RR′ and MS which match those of 3. The area ratio between the two peaks of the chromatogram was 15/3 ) 6:1, whereas relative proportions between the sterols measured in P. blakesleeanus was 15/3 ) 1:7. These facts point to a true metabolic origin for the major part of neoergosterol (3) found in Phycomyces.
Phycomysterols A (1) and B (2), as well as neoergosterol (3), co-occur with sterols 11, 12, and 16 in P. blakesleeanus. From a structural point of view, biogenesis of 1-3, from 11, 16, and 12, respectively, seems plausible.
Finally, the biological activity of phycomysterol A (1) was tested against the human inmunodeficiency virus (HIV) 32 and on several human and mouse tumor cell lines. 33 Sterol 1 displayed medium anti-HIV activity at a concentration nontoxic for the infected human cells. Several HIVinhibitory sulfated sterols from marine invertebrates have been reported previously 34 but anti-HIV activity of a nonsulfated aromatic sterol is novel.
Experimental Section
General Experimental Procedures. Optical rotations were determined on a Perkin-Elmer 141 polarimeter. IR spectra were obtained, in liquid film between NaCl plates, on a 983 G Perkin-Elmer apparatus. HRMS were measured on an Autospec-Q VG-Analytical (FISONS) mass spectrometer, and LRMS were determined on a 5988A Hewlett-Packard instrument. NMR spectra were recorded on Bruker AM 300 and Bruker ARX 400 spectrometers. Chemical shifts are reported in parts per million (δ) relative to TMS and coupling constants (J) are in Hertz. 13 C NMR assignments are tentative unless otherwise stated. Carbon substitution degrees were established by DEPT multipulse sequence. Thin-layer chromatography (TLC) was performed on precoated 0.25-mm thick Merck plates of Si gel 60 F 254, using a 7% phosphomolybdic acid solution (EtOH) to visualize the spots. Semipreparative TLC was performed on precoated 0.5-mm thick Scharlau plates of Si gel F 254. Gravity column chromatography was carried out on Brockmann type Al2O3 and flash chromatography was performed as described previously. 35 All solvents were purified and dried following standard procedures. 36 Cholesterol was purchased from BDH Chemicals Ltd and ergosterol from Aldrich. Other reagents were purchased from Aldrich, Merck, or Fluka and were used as received.
Organism. An aqueous spore suspension (1.2 × 10 7 spores per mL) of P. blakesleeanus (NRRL1555 wild strain) was obtained from Prof. E. Cerdá -Olmedo, Departamento de Genética, Universidad de Sevilla, Sevilla, Spain.
Culture and Extraction Procedures. Minimal medium 37 (4 L) was autoclaved at 120°C for 15 min (glucose was autoclaved separately) and distributed in forty 500 mL Erlenmeyer flasks. Fungal spores were activated by heat shocking the spore suspension (48°C for 10 min) immediately before inoculation. The liquid medium was inoculated (7 × 10 5 spores per L) with the activated spore suspension. The flasks were incubated at 23°C, under the light of four 40 W fluorescent lamps, at 200 rpm for 5 days. The fungal mycelium, harvested by vacuum filtration and then lyophilized, weighed 26.56 g. The lyophilized mycelium was ground and extracted with t-BuOMe. The extract was divided into neutral (5.66 g) and acidic (2.25 g) parts. The neutral part was chromatographed over an Al 2O3 column, using hexane/t-BuOMe mixtures of increasing polarity. Sterol esters (139 mg) were eluted with hexane/t-BuOMe (8:2), triterpenoids (33 mg) were eluted with hexane/t-BuOMe (2:8), and free sterols (24 mg) were eluted with t-BuOMe. The sterol esters were saponified and the nonsaponifiable fraction (57 mg) was rechromatographed in eight subfractions using reverse phase HPLC (Spherisorb ODS-2 column, 250 × 4.6 mm i.d.) and MeOH as eluant (4 mL per min). These subfractions were derivatized and analyzed by GC-MS together with the free sterol fraction.
Preparation of TMS Derivatives and Analysis by GC-MS: Anhydrous THF (10 µL) and 10 µL of BSTFA were added per mg of sample, and the mixture was heated at 110°C in a sealed vial for 20 min. The solvent and reagents were evaporated, and the residue was redissolved in THF (0.1 mL per mg). One µL of sample was injected into a 25 m × 0.32 mm i.d. HP-1 methylsilicone capillary column (He at 0.6 mL‚min -1 ; temperature programmed from 80 to 260°C at 40°C ‚min -1 , from 260 to 280°C at 3°C‚min -1 , and 30 min hold at 280°C; injector temperature 260°C; 70 eV; ion source at 150°C). 19-Norergosta-5,7,9,22-tetraen-3 -yl Acetate (22). This compound was obtained from ergosterol (12) by the photochemical procedure previously reported. 27 20-Formyl-19-norpregna-5,7,9-trien-3 -yl Acetate (23). A current of freshly generated ozone was passed through a solution of 22 (800 mg) in anhydrous CH2Cl2 (65 mL) and pyridine (0.32 mL) at -50°C for 6 h. An 8 mL amount of Me2S was then added, and the stirred mixture was allowed to return to room temperature. The reaction mixture was washed with saturated solutions of KHSO4 and NaHCO3 and dried over anhydrous Na2SO4. The solvent was removed, and the crude residue was flash chromatographed ( (24 a,b) . Buthyllithium (2.4 mL of a 2.5 M solution in hexane) was added to a solution of diisopropylamine (0.84 mL) in anhydrous THF (6.6 mL) at -78°C under Ar. After 20 min a solution of 3-methyl-2-butanone (0.64 mL) was added and the mixture stirred for 15 min. The resulting enolate was transferred by means of a cannula into a previously cooled solution (-78°C) of 23 (500 mg) in THF (4 mL). The reaction mixture was left at 0°C for 1 h and was poured into a saturated solution of NH4Cl (20 mL). The solution was extracted with AcOEt (40 mL × 4), and the organic layers were washed with 1 M HCl, saturated NaHCO3, and brine and then dried over anhydrous Na2SO4. When the solvent was eliminated, a crude residue (799 mg) was obtained, which was flash chromatographed (hexane, t-BuOMe 7:3) yielding 162 mg of 22R-hydroxy-19-nor-24-oxoergosta-5,7,9-trien-3 -yl acetate (24a): oil; IR (film) νmax 3500, 1731, 1713 cm 13 1-3, 5, 7, 10, 15, and 23 (3:1) (12 mL) was treated with p-toluenesulfonic acid (18 mg) and anhydrous MgSO4 (370 mg), and the solution was stirred at 70°C for 1 h. The reaction mixture was then filtered, diluted with ether (50 mL), and washed with a saturated solution of NaHCO3 (25 mL × 3) and then brine. The organic layer was dried over anhydrous Na2SO4 and filtered, and the solvent was removed to give a residue which was flash chromatographed (hexane, t-BuOMe 85: 15) 19-Norergosta-5,7,9,22-tetraen-3 -ol (3). The acetate 22 (400 mg) was dissolved in 25 mL of 1 N KOH/MeOH. The solution was refluxed for 30 min, and then the EtOH was removed and 50 mL of water was added. The mixture was extracted with ether (40 mL × 3), and the organic layers washed together with brine and dried over anhydrous Na 2- Synthesis of Ergosta-5,8,22-trien-3 -ol (15). This sterol was obtained from compound 27 by the procedure previously described. 30 1 H NMR data, mp, and [R] 25 D were in agreement with those previously reported; 30 13 C NMR (Table 2) ; HREIMS m/z 396.3392 (calcd for C28H44O, 396.3392). Cholesterol (0.25 mg) was added to 1 mg of 15. The mixture was derivatized with BSTFA and analyzed by GC-MS. The chromatogram showed two peaks: the major peak had TRR′ (1.070) and MS identical to those for TMS ether of fungal lichesterol, whereas TRR′ (1.090) and MS of the minor peak (17% abundance relative to the major peak) coincided with those obtained from TMSether of neoergosterol.
EIMS Data of TMS-Ethers from
Synthesis of Ergosta-5,8(14),22-trien-3 -ol (30). The intermediate 28 (44 mg) was dissolved in ethylamine (2 mL), treated with lithium (35 mg), and stirred at -20°C for 1 h. A 4 mL amount of water was then added, and the suspension was extracted with t-BuOMe. The organic layer was washed with brine and dried over anhydrous Na2SO4. After removal of the solvent a crude (27 mg) was obtained, which was flash chromatographed (hexane/t-BuOMe 1:1) yielding 13 mg of the sterol 30:
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